Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE:MTEC, Frankfurt:3CM), a leading business technology company in the cannabis space, continues to develop a substantial set of educational modules surrounding the consumption of cannabis-infused food and beverages for its Cannvas.Me educational platform. Leveraging the Company’s Health and Innovation Advisory Board, Medical Advisory Board and Education Advisory Panel, made up of members from industry and government institutions, Cannvas.Me will deliver comprehensive and credible information on the potential benefits of cannabis-infused edibles.

“We see immense opportunity for Cannvas.Me to become a leader in education on the subject of cannabis-infused food and beverage for medicinal and adult-use cannabis users, particularly with the emergence of major brands partnering with cannabis producers to explore this space,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “International companies are rushing to cannabis to create trendy and innovative consumer products and there is little credible information available to the public on whether these products will be beneficial to their lifestyle, a gap we expect to fill with our educational platform Cannvas.Me.”

As The Company continues to grow, recently expanding its team to 19 members and actively growing its partnership base with national and international organizations, it intends to harness the expertise of its staff, who bring with them years of experience working with food and beverage clients across Canada, to further guide content creation centered around cannabis-infused food and beverage. Cannvas recently hired Daniel Davidzon, who brings with him a wealth of experience in the foodservice industry including having helped grow Aroma Espresso Bar Canada from 20 to 46 locations in a four-year span.

“I look forward to sharing my expertise in foodservice and hospitality and staying on top of industry trends with the Cannvas.Me Health and Innovation Advisory Board, Medical Advisory Board and Education Advisory Panel to enrich the content our platform offers our users,” said Daniel Davidzon, Marketing Manager, Cannvas MedTech Inc. “We intend to stay at the forefront of the food and beverage industry not only in regards to cannabis-infused edibles but overall food trends to ensure we deliver credible information, quality recipes and the latest insights into the use of cannabis in edible or drinkable form.”

Cannvas.Me is a scalable and comprehensive solution for the global medical cannabis community offering interactive tools and physician-backed content to audiences wishing to learn about healthcare through cannabis. Its Cannvas Culinary educational modules encourage users to browse recipes and expert advice on cannabis consumption from accomplished chefs and cannabis advocates, dispelling the stigma that edibles only comprise candy, chocolate, cookies, or other sugar-filled desserts by showcasing simple and nutritious alternatives. Cannvas recently named Cody Lindsay, a veteran of the Canadian military, chef, cannabis advocate, and owner of The Wellness Soldier, as the featured expert for culinary cannabis on its learning platform Cannvas.Me

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

For additional information:

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted

For further information: Media Inquiries:; Investor Relations,, 1-800-489-0116

Click here to connect with Cannvas MedTech Inc. (CSE:MTEC, Frankfurt:3CM) for an Investor Presentation.


Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less


Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit:

Keep reading... Show less